Published in Hospital Law Weekly, December 20th, 2007
"We analyzed the incidence, clinical presentation, outcome and risk factors, including HGG, of CDAD after HT. Two hundred thirty-five patients who underwent HT (1993 to 2005) were included. Transplantation procedure and immunosuppression were standard....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly